• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NOX

NOXOPHARM LIMITED

16.0% ! 10.5¢
Market Cap $30.68M  !

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel... Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NOX 30/07/25 3 778
30/07/25 Last post  No_8 Comments Created with Sketch.  3  Views Created with Sketch.  778 
NOX 29/07/25 5 1.9K
29/07/25 Last post  Pierzzxx Comments Created with Sketch.  5  Views Created with Sketch.  1.9K 
NOX 21/07/25 3 1.8K
21/07/25 Last post  19661966 Comments Created with Sketch.  3  Views Created with Sketch.  1.8K 
NOX
Noxopharm gets HERACLES autoimmune trials started with first human doses
16/07/25 0 283
16/07/25 Last post  ASX Insights Comments Created with Sketch.  0  Views Created with Sketch.  283 
NOX 11/07/25 9 3.4K
11/07/25 Last post  Bendunstan Comments Created with Sketch.  9  Views Created with Sketch.  3.4K 
NOX 24/06/25 19 6.0K
24/06/25 Last post  19661966 Comments Created with Sketch.  19  Views Created with Sketch.  6.0K 
NOX 10/06/25 4 1.8K
10/06/25 Last post  19661966 Comments Created with Sketch.  4  Views Created with Sketch.  1.8K 
NOX 28/05/25 15 4.9K
28/05/25 Last post  19661966 Comments Created with Sketch.  15  Views Created with Sketch.  4.9K 

See All Discussions arrow Created with Sketch.

Timeline

June 2025 Quarterly Activities Report and Appendix 4C
30 Jul 08:30
 
HERACLES clinical trial - Update 1
28 Jul 09:39
 
First SOF-SKN dose in HERACLES clinical trial
16 Jul 08:14
 
Clinical trial recruitment progressing rapidly
25 Jun 10:08
 
Promising Sofra results from overseas company
11 Jun 11:11
 
Green light for HERACLES clinical trial
29 May 08:37
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
10.5¢
Change
-0.020(16.0%)
Mkt cap ! $30.68M
Open High Low Value Volume
12.0¢ 12.0¢ 10.5¢ $9.914K 86.45K

Buyers (Bids)

No. Vol. Price($)
3 35212 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 43135 1
View Market Depth
Last trade - 15.51pm 31/07/2025 (20 minute delay) ?
Last
11.0¢
  Change
-0.020 ( 7.80 %)
Open High Low Volume
11.5¢ 11.5¢ 10.5¢ 79061
Last updated 15.58pm 31/07/2025 ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.